Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects

Area of Science:

• Nanomedicine
• Biomedical Research
• Materials Science

Background:

• Cellular labeling with nanoparticles is crucial for noninvasive monitoring in transplantation studies.
• Assessing nanoparticle toxicity is complex due to varied research parameters and inconsistent results.
• Iron oxide nanoparticles are widely used but their safety profile requires thorough investigation.

Purpose of the Study:

• To provide an overview of nanomaterials, particularly iron oxide nanoparticles, for biomedical research.
• To discuss the challenges in evaluating nanoparticle-mediated toxicity.
• To suggest novel methods for assessing toxicity, focusing on intracellular degradation and functional nanoparticle levels.

Main Methods:

• Literature review of nanomaterials and their applications in cell labeling.
• Analysis of existing data on nanoparticle toxicity, with a focus on iron oxide nanoparticles.
• Discussion of key parameters influencing toxicity assessments and proposed new methodologies.

Main Results:

• Disparate results exist in the literature regarding nanoparticle toxicity.
• Commercial dextran-coated iron oxide nanoparticles present specific challenges in toxicity assessment.
• Intracellular nanoparticle degradation and functional cell-associated levels are critical factors for toxicity evaluation.

Conclusions:

• In-depth study of cell-nanoparticle interactions is essential to ensure safety in cell-based therapies.
• Standardized methods are needed to accurately assess nanoparticle toxicity.
• Linking toxicity data to functional nanoparticle levels can advance nanomedicine research.